Dr. Christopher Paul Downing, MD

Dr. Downing practices at Houston Dermatology Specialists in Houston, Texas.

Dr. Downing's NPI, 1780939405, was assigned on July 18, 2012. Dr. Downing graduated from University Of Florida College Of Medicine in 2012. Dr. Downing holds Texas license P7102.

Dr. Downing's primary practice is Houston Dermatology Specialists, at 909 Frostwood Dr, Houston, TX 77024 in Harris County. The practice phone is (713) 487-8233.

Dr. Downing's primary practice is Houston Dermatology Specialists in Houston, Texas. The medical group on file is Houston Dermatology Specialists. Dmand AI also links Dr. Downing to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Downing practices. Vendor and product names are available with a free account.

Dermatology is Dr. Downing's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Downing is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Downing's licenses on file in 3 states: Texas, Florida and Illinois.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, itchy rashes and joint cyst among the conditions Dr. Downing treats.

CMS data shows 4,963 Medicare services from Dr. Downing across 34 procedure codes in 2024, for 536 Medicare patients. Medicare paid $770,985 for them. Every service was in an office.

CMS counts 536 Medicare patients who saw Dr. Downing in 2024. The largest group is 65 to 74, with 318 patients. 75% of them have high cholesterol, and 73% have high blood pressure. Their average risk score is 1.04, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Downing's median patient age at 67, with 44% women.

In 2024, Dr. Downing wrote 1,459 Medicare Part D claims for 586 patients. 96% of them were for generic drugs. CMS names the drug for 1,338 of them, across 21 drugs with 11 or more claims each, at $160,226 in total drug cost. In 2023, CMS named 1,011 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 38 out of 100 for Dr. Downing for performance year 2024, reported individually. Dr. Downing accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 824 procedures of skin biopsy by Dr. Downing, more than 98% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 16 papers to Dr. Downing, published from 2013 to 2022. 2015 was the busiest year, with 4. The most frequent topics are Disease Progression, Biopsy, Needle and Diagnosis, Differential. Dr. Downing has published most often in J Clin Med. Dr. Downing's most frequent co-authors are Stephen Keith Tyring, MD, PhD, Jacqueline A. Guidry, MD and Farhan Khan, MD.

CMS Open Payments shows 464 general payments to Dr. Downing from 39 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Abbvie Inc. paid the most, $1,848.

Dr. Downing graduated from University Of Florida College Of Medicine in 2012.

Dr. Downing is in network with 22 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.